A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...
MedPage Today on MSN
GLP-1 agents showed broader risks, rewards in 2025
While the FDA has yet to issue a warning for NAION, it is actively monitoring reports of the condition linked to GLP-1 drugs.
A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...
GLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that weight loss treatments using GLP-1 and ...
Researchers say a woman struggling with obesity who couldn't resist eating fatty foods experienced declines in her cravings after taking tirzepatide, the GLP-1 weight-loss drug used in Mounjaro and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results